期刊文献+

肺腺癌CT征象与表皮生长因子受体基因突变的相关性研究 被引量:17

Correlation between CT characters and epidermal growth factor receptor gene mutations in lung adenocarcinoma
原文传递
导出
摘要 目的:探究肺腺癌CT征象与表皮生长因子受体(EGFR)基因突变的相关性。方法回顾性分析2014年9月至2015年3月间203例经病理证实为肺腺癌患者CT资料,将突变情况根据这些位点与酪氨酸激酶抑制剂的疗效关系,分为有效突变组(97例)及非有效突变组(106例)。在所有的CT征象中,肿块直径采用秩和检验,密度采用Fisher精确概率法,其余征象(分叶征、毛刺征、坏死征、胸膜凹陷征、空洞征及空气支气管征)采用卡方检验对数据进行初步分析,再将有统计学意义的征象用logistic回归进行分析,计算优势比(OR)。结果在EGFR基因有效突变组,分叶征、毛刺征、坏死征、胸膜凹陷征分别为65、67、45、74例,非有效突变组对应的例数分别为56、51、26、61例,两组间差异具有统计学意义(χ^2值分别为4.230、9.141、10.646、7.986,P〈0.05)。病灶直径、密度、空洞征、空气支气管征在两组间差异没有统计学意义(P〉0.05)。Logistics回归分析显示:毛刺征(OR=2.120)、坏死征(OR=2.853)及胸膜凹陷征(OR=2.094)与EGFR有效突变有关(P〈0.05),而分叶征与EGFR有效突变无关。结论在所有的CT征象中,毛刺征、坏死征及胸膜凹陷征与EGFR基因有效突变有关,它们更容易出现在有EGFR基因有效突变的肺腺癌患者中。 Objective To explore the correlation between CT characters and epidermal growth factor receptor (EGFR) gene mutations in lung adenocarcinoma. Methods Two hundred and three lung adenocarcinoma patients (from September,2014 to March,2015) confirmed by pathology were divided into effective mutation group (97 cases) and non-effective mutation group (106 cases) on the basis of the site and the response to tyrosine kinase inhibitors. Among all the CT characters, rank-sum test was adopted to analyze the difference of diameter between the two groups; Fisher's exact test was applied to explain the difference of density type and Chi-square test was applied to analyze the difference of lobulation, spiculation, necrosis, pleural indentation, cavitation and air-brochogram signs. Logistic regression was used to analyze the significant signs and evaluate the odds ratio (OR). Results There were 65, 67, 45, 74 cases of lobulation, spiculation, necrosis, pleural indentation in the EGFR gene effective mutation group and 56, 51, 26, 61 cases in non effective mutation group with statistically significant difference between the two groups (χ^2=4.230, 9.141, 10.646, 7.986, P〈0.05). However, there were no significant difference between the two groups in the diameter, density, cavitation and air-brochogram (P〉0.05). Logistics regression analysis showed that, spiculation (OR=2.120), necrosis (OR=2.853) and pleural indentation (OR=2.094) were in correlation with EGFR effective mutations, and lobulation was not in correlation with EGFR effective mutations. Conclusions Among all the CT sings, spiculation, necrosis and pleural indentation were in correlation with EGFR gene effective mutation, they were more likely to appear in lung adenocarcinoma patients with EGFR gene effective mutation.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2016年第6期416-420,共5页 Chinese Journal of Radiology
关键词 肺肿瘤 受体 表皮生长因子 基因表达 体层摄影术 X线计算机 Lung neoplasms Receptor, epidermal growth factor receptor Gene expression Tomography, X-ray computed
  • 相关文献

参考文献16

  • 1Gevaert O, Xu J, Hoang CD, et al. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results[J]. Radiology, 2012, 264(2): 387-396. DOI:10.1148/radiol.12111607. 被引量:1
  • 2Antonicelli A, Cafarotti S, Indini A, et al. EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation[J]. Int J Med Sci, 2013, 10(3): 320-330. DOI: 10.7150/ijms.4609. 被引量:1
  • 3Kyle F, Spicer J. Targeted therapies in non-small cell lung cancer[J]. Cancer Imaging, 2008, 8: 199-205. DOI:10.1102/ 1470-7330.2008.0027. 被引量:1
  • 4Pirker R, Filipits M. Targeted therapies in lung cancer[J]. Curr Pharm Des, 2009, 15(2): 188-206. 被引量:1
  • 5Hellmann MD, Reva B, Yu H, et al. Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib[J]. J Thorac Oncol, 2014, 9(10): e73-e74. DOI:10.1097/JTO.0000000000000221. 被引量:1
  • 6He M, Capelletti M, Nafa K, et al. EGFR exon 19 insertions: a family of sensitizing EGFR mutations in lung adenocarcinoma[J]. Clin Cancer Res, 2012, 18(6): 1790-1797. DOI:10.1158/1078-0432.CCR- 11-2361. 被引量:1
  • 7Arcila ME, Nafa K, Chaft JE, et al. EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics[J]. Mol Cancer Ther, 2013, 12(2): 220-229. DOI:10.1158/1535-7163. MCT-12-0620. 被引量:1
  • 8Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging[J]. Radiology, 2008, 246(3): 697-722. DOI: 10.1148/radiol.2462070712. 被引量:1
  • 9Yamashita K, Matsunobe S, Tsuda T, et al. Intratumoral necrosis of lung carcinoma: a potential diagnostic pitfall in incremental dynamic computed tomography analysis of solitary pulmonary nodules[J]. J Thorac Imaging, 1997, 12(3): 181-187. 被引量:1
  • 10Rizzo S, Petrella F, Buscarino V, et al. CT Radiogenomic Characterization of EGFR, K- RAS, and ALK Mutations in Non-Small Cell Lung Cancer[J]. Eur Radiol, 2016, 26(1): 32- 42. DOI: 10.1007/s00330-015-3814-0. 被引量:1

二级参考文献16

  • 1党亚萍,刘刚,王红,李苗.PET/CT对肺内结节诊断及治疗的临床价值[J].中华肿瘤杂志,2004,26(11):685-687. 被引量:20
  • 2Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J].N Engl J Med, 2004, 350(21 ):2129-2139. 被引量:1
  • 3Paez JG, ,lanne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinibtherapy [J].Science, 2004, 304 (5676): 1497-1500. 被引量:1
  • 4Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologiccomparisons[J].Radiology, 2007, 245 (1): 267-275. 被引量:1
  • 5Lee SM, Park CM, Goo JM, et al. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features[J]. Radiology, 2013, 268 ( 1 ) :265-273. 被引量:1
  • 6Park EA, Lee HJ, Kim YT, et al. EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: investigation of significantly related factors on CT, FDG-PET, and histopathology[J].Lung Cancer, 2009, 64 (2): 179-186. 被引量:1
  • 7Yano M, Sasaki H, Kobayashi Y, et al. Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma[J].J ThoracOncol, 2006, 1(5):413-416. 被引量:1
  • 8Lee Y, Lee HJ, Kim YT, et al. Imaging characteristics of stage I non-small cell lung cancer on CT and FDG-PET: relationship with epidermal growth factor receptor protein expression status and survival[J].Korean J Radiol, 2013, 14 (2):375-383. 被引量:1
  • 9Onn A, Choe DH, Herbst RS, et al. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome[J]. Radiology, 2005, 237( 1 ) :342-347. 被引量:1
  • 10Franklin WA, Veve R, Hirsch FR, et al. Epidermal growth factor receptor family in lung cancer and premalignancy[J]. SeminOncol, 2002, 29( 1 Suppl 4):3-14. 被引量:1

共引文献106

同被引文献81

引证文献17

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部